As HIV continues to develop resistance to the present antiretrovirals a new class of drugs offer hope for the treatment of AIDS.

The US Animal Welfare Act for humane care of research animals excludes rats, mice and birds. Efforts to remedy this are in progress.

A new research centre is being established in Singapore that will use a multidisciplinary approach to study systems biology.

Vitamin C could promote production of DNA-damaging compounds and may help explain why vitamin C has thus far shown little effectiveness at preventing cancer in clinical trials.

The world's most powerful, high-resolution nuclear magnet resonance spectrometer provides researchers with the ability to determine structures of high molecular weight proteins and nucleic acids with much greater sensitivity and resolution.

can quickly become resistant to linezolid during extended treatment.

The recent American College of Cardiology meeting provided a striking example of how the new technology of combinatorial chemistry is changing the face of the drugs market.

In a bid to rival San Diego and Boston as a centre for biomedical research and technology transfer, Houston has just announced the $633 million, 64-acre Southeast Texas Biotechnology Park.

The German government has just announced a $425 million, three-year genome research funding program. This type of government support, and the revision of federal laws are promoting a growth spurt in the German biotechnology industry.

res at a daily treatment cost of less than one dollar.

US FDA user fees may have accelerated new drug development but a recent survey suggests difficulties in obtaining volunteers for human clinical trials still slow progress.

Bristol-Myers Squibb's novel patent strategy could prove effective in protecting its marketing exclusivity for the blockbuster anxiety drug BuSpar.